IVF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
INVO Fertility Inc (IVF) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, and the company is currently unprofitable with declining EPS. Although revenue and gross margin have shown growth, the lack of positive trading signals, recent news catalysts, or strong analyst upgrades makes this stock a hold rather than a buy.
The technical indicators suggest a bearish trend. The MACD is below zero and negatively contracting, the RSI is neutral at 28.071, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot point of 2.884, with key support at 2.331 and resistance at 3.437.
Revenue increased by 22.60% YoY in Q3 2025, and gross margin improved by 87.56% YoY.
There are no recent news catalysts or significant trading trends from hedge funds or insiders.
In Q3 2025, revenue increased to 1,757,094 (up 22.60% YoY), net income improved to -2,644,625 (up 62.18% YoY), EPS dropped to -6.14 (down -94.92% YoY), and gross margin increased to 28.04% (up 87.56% YoY).
Maxim upgraded INVO Fertility to Buy from Hold with a $4 price target on 2026-02-10, indicating moderate optimism. However, there are no other recent analyst updates.
